JEFFREY C REBISH

Allopathic & Osteopathic Physicians|Dermatology UPLAND, CA NPI 1558452425

General Payments — all program years on this page

$2,364.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $957.03 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $957.0322

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $338.8415
2019 $620.1918
2020 $81.314
2021 $178.118
2022 $147.347
2023 $41.501
2024 $957.0322

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078349548 Janssen Biotech, Inc. $0.52 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078349898 Janssen Biotech, Inc. $130.01 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078349931 Janssen Biotech, Inc. $11.13 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078349949 Janssen Biotech, Inc. $98.05 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087327567 Novartis Pharmaceuticals Corporation $106.64 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105926815 ABBVIE INC. $29.83 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105926817 ABBVIE INC. $15.05 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105926819 ABBVIE INC. $33.88 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105926821 ABBVIE INC. $21.65 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105926823 ABBVIE INC. $15.98 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131164345 PFIZER INC. $17.11 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131841854 PFIZER INC. $17.97 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139713460 GENZYME CORPORATION $44.16 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139713526 GENZYME CORPORATION $18.72 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141262973 Incyte Corporation $53.73 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141304401 Incyte Corporation $64.42 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143238234 UCB, Inc. $32.25 02/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145323043 Galderma Laboratories, L.P. $68.24 02/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145323045 Galderma Laboratories, L.P. $52.38 03/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145323047 Galderma Laboratories, L.P. $19.79 03/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152158531 SUN PHARMACEUTICAL INDUSTRIES INC. $57.41 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152158533 SUN PHARMACEUTICAL INDUSTRIES INC. $48.11 02/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.